Active: new fund Aug 2026 Verified 4 Nov 2026
Andreessen Horowitz (a16z)
Silicon Valley venture capital firm with focus areas including AI, American dynamism, bio and health, consumer, enterprise, fintech, infrastructure and growth. Based in Menlo Park, CA.
- Type
- VC firm
- Location
- Menlo Park, California, United States
- Stages
- Seed, Series A, Series B, Growth
- Sectors
- AI, Defense, Healthtech and life sciences, Consumer, B2B, Fintech, Biotech, SaaS and software
- Fund size / AUM
- Size not stated (Form D, Carolah Opportunities I, filed 2026-08-10); 18 fund vehicles filed in the last 12 months
- Latest fund or filing
- 10 Aug 2026
- Website
- a16z.com
Contacts on file
For Andreessen Horowitz (a16z), the paid file holds: 2 named decision-makers with roles; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/2126664/000110465926092897/
- adviserinfo.sec.gov/firm/summary/160489
- a16z.com/
- a16z.com/about/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 127 lists
Defense tech investors in Silicon Valley (16)Growth-stage defense tech investors in the US (20)Series B B2B investors in the US (27)Series A defense tech investors in the US (27)Series B investors in Silicon Valley (29)Series B defense tech investors (29)Series B consumer investors in the US (29)Defense tech investors in the San Francisco Bay Area (31)Series B biotech investors in the US (34)Growth-stage investors in Silicon Valley (41)Consumer investors in Silicon Valley (43)Growth-stage defense tech investors (44)Growth-stage biotech investors in the US (44)Defense tech investors in California (45)Series B B2B investors (46)B2B investors in Silicon Valley (47)Biotech investors in Silicon Valley (48)Growth-stage B2B investors in the US (54)Series B consumer investors (59)Series B fintech investors in the US (59)Series A biotech investors in the US (59)Series B investors in California (60)Growth-stage consumer investors in the US (60)Fintech investors in Silicon Valley (62)Series A investors in Silicon Valley (67)Series A defense tech investors (67)Series B healthtech investors in the US (69)Growth-stage investors in the San Francisco Bay Area (71)Series B biotech investors (73)Seed defense tech investors in the US (73)Series A B2B investors in the US (79)Series A consumer investors in the US (80)B2B investors in the San Francisco Bay Area (84)Consumer investors in the San Francisco Bay Area (86)Biotech investors in the San Francisco Bay Area (88)Growth-stage investors in California (89)Healthtech investors in Silicon Valley (91)Growth-stage fintech investors in the US (97)Biotech investors in California (108)Series B SaaS investors in the US (108)Growth-stage biotech investors (109)B2B investors in California (109)Series A investors in the San Francisco Bay Area (112)Growth-stage B2B investors (119)Growth-stage healthtech investors in the US (121)Seed defense tech investors (123)Growth-stage consumer investors (124)Series B AI investors in the US (126)Series B fintech investors (127)Defense tech venture capital firms in the US (130)Consumer investors in California (130)Series A investors in California (136)Fintech investors in the San Francisco Bay Area (140)Series A fintech investors in the US (145)Seed investors in Silicon Valley (152)Series A biotech investors (153)Series A consumer investors (154)Series A B2B investors (157)Seed biotech investors in the US (159)Series B healthtech investors (160)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Series A healthtech investors in the US (164)Series B investors in the US (165)SaaS investors in Silicon Valley (169)AI investors in Silicon Valley (172)Healthtech investors in the San Francisco Bay Area (182)Seed B2B investors in the US (183)Fintech investors in California (189)Defense tech investors (196)Series B SaaS investors (196)Series B AI investors (204)Growth-stage fintech investors (214)Seed consumer investors in the US (216)Healthtech investors in California (240)Series A SaaS investors in the US (256)B2B venture capital firms in the US (257)Series A AI investors in the US (280)Growth-stage investors in the US (288)Series A fintech investors (294)Growth-stage AI investors (295)Biotech venture capital firms in the US (297)Seed biotech investors (300)Seed B2B investors (302)Growth-stage healthtech investors (316)Seed investors in the San Francisco Bay Area (324)Seed consumer investors (331)Series B investors (339)Venture capital firms in Silicon Valley (341)Growth-stage SaaS investors (344)SaaS investors in the San Francisco Bay Area (347)Consumer venture capital firms in the US (348)Seed fintech investors in the US (349)AI investors in the San Francisco Bay Area (364)Series A investors in the US (372)Series A healthtech investors (401)Seed investors in California (415)SaaS investors in California (433)Seed healthtech investors in the US (437)B2B investors (438)AI investors in California (464)Series A SaaS investors (475)Biotech investors (484)Series A AI investors (500)Consumer investors (512)Fintech venture capital firms in the US (525)Seed fintech investors (584)Seed SaaS investors in the US (666)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Venture capital firms in the San Francisco Bay Area (768)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Seed SaaS investors (1,010)Venture capital firms in California (1,038)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)